Professor | Yanwei Wu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yanwei Wu
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Yanwei Wu

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Shanghai University
Faculty	Medicine
Academic Background & Achievements	2011 - Bachelor in Pharmacy: Tongji Medical College, Huazhong University of Science and Technology 2016 - PhD: Shanghai Institute of Materia Medica, Chinese Academy of Sciences Held multiple project leadership roles including national key R&D programs and grants Shanghai Pharmaceutical Science Technology Award (First Prize) for Basic Research
Work Experience	2016 - Present - Shanghai Institute of Materia Medica: Assistant Researcher, Associate Researcher 2022 - Present - Shanghai University Medical School: Associate Researcher
Awards	Shanghai Pharmaceutical Science Technology Award (First Prize): For Basic Research

University/Lab Affiliation and Title

Shanghai University

Faculty

Medicine

Academic Background & Achievements

2011 - Bachelor in Pharmacy: Tongji Medical College, Huazhong University of Science and Technology
2016 - PhD: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Held multiple project leadership roles including national key R&D programs and grants
Shanghai Pharmaceutical Science Technology Award (First Prize) for Basic Research

Work Experience

2016 - Present - Shanghai Institute of Materia Medica: Assistant Researcher, Associate Researcher
2022 - Present - Shanghai University Medical School: Associate Researcher

Awards

Shanghai Pharmaceutical Science Technology Award (First Prize): For Basic Research

Areas of Focus	Autoimmune and inflammatory diseases Early events in viral infections and drug development
Publications	Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way, Wu YW, Wu B, Zhang ZW, Lu HM, Fan C, Qi Q, Gao YZ, Li H, Feng CL, Zuo JP, Tang W, 2020 A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage, Huang S, Wu Y, Zhao Z, Wu B, Sun K, Wang H, Qin L, Bai F, Leng Y, Tang W, 2021 Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation, Wu YW, He SJ, Bai BX, Zhang LY, Xue L, Lin ZM, Yang XQ, Zhu FH, He PL, Tang W, Zuo JP, 2016 Hemin protects against Zika virus infection by disrupting virus-endosome fusion, Xu MM, Wu B, Huang GG, Feng CL, Wang XH, Wang HY, Wu YW, Tang W, 2022 STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion, Wu B, Xu MM, Fan C, Feng CL, Lu QK, Lu HM, Xiang CG, Bai F, Wang HY, Wu YW, Tang W, 2021 Development of artemisinin drugs in the treatment of autoimmune diseases, Wu YW, Tang W, Zuo JP, 2016

Areas of Focus

Autoimmune and inflammatory diseases
Early events in viral infections and drug development

Publications

Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way, Wu YW, Wu B, Zhang ZW, Lu HM, Fan C, Qi Q, Gao YZ, Li H, Feng CL, Zuo JP, Tang W, 2020
A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage, Huang S, Wu Y, Zhao Z, Wu B, Sun K, Wang H, Qin L, Bai F, Leng Y, Tang W, 2021
Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation, Wu YW, He SJ, Bai BX, Zhang LY, Xue L, Lin ZM, Yang XQ, Zhu FH, He PL, Tang W, Zuo JP, 2016
Hemin protects against Zika virus infection by disrupting virus-endosome fusion, Xu MM, Wu B, Huang GG, Feng CL, Wang XH, Wang HY, Wu YW, Tang W, 2022
STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion, Wu B, Xu MM, Fan C, Feng CL, Lu QK, Lu HM, Xiang CG, Bai F, Wang HY, Wu YW, Tang W, 2021
Development of artemisinin drugs in the treatment of autoimmune diseases, Wu YW, Tang W, Zuo JP, 2016

Autoimmune Diseases Inflammatory Diseases Systemic Lupus Erythematosus Multiple Sclerosis Inflammatory Bowel Disease Psoriasis Non-Alcoholic Steatohepatitis Drug Research Viral-Host Interaction Antiviral Drugs

Yanwei Wu - Shanghai University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us